7 Result(s)

Article

Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) patients are at a high risk of develo** metastases in the brain. However, research focusing on treatment strategies for hormonal r...

Dongshao Chen, Fei Xu, Yongkui Lu, Wen **a, Caiwen Du, Dun **ong… in npj Breast Cancer (2024)

Article

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes

We aimed to identify the relationship between the genomic characteristics and clinical outcomes of oligo-metastatic breast cancer.

Kuikui Jiang, Danyang Zhou, Fei Xu, Wen **a, Qiufan Zheng, Qianyi Lu… in BMC Cancer (2023)

Article

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer

This study aimed to investigate the prognostic value of AR in HER2+ nonmetastatic breast invasive ductal carcinoma (IDC) and its relationship with the immune microenvironment. HER2+ nonmetastatic breast IDC pa...

Danyang Zhou, Mei Li, Mohamed Hussein Yasin, Qianyi Lu, Jia Fu… in npj Breast Cancer (2023)

Article

Comorbidity in lung cancer patients and its association with hospital readmission and fatality in China

Comorbidity has been established as one of the important predictors of poor prognosis in lung cancer. In this study, we analyzed the prevalence of main comorbidities and its association with hospital readmissi...

Dawei Zhu, Ruoxi Ding, Yong Ma, Zhishui Chen, Xuefeng Shi, ** He in BMC Cancer (2021)

Article

Comorbidity in lung cancer patients and its association with medical service cost and treatment choice in China

It is evident that comorbidity exacerbate the complexity of the management of lung cancer, however, limited research has been conducted to investigate the impact of comorbidity on health service utilization an...

Ruoxi Ding, Dawei Zhu, ** He, Yong Ma, Zhishui Chen, Xuefeng Shi in BMC Cancer (2020)

Article

Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells

Ruoxi Hong, Fei Ma, Weimin Zhang, **ying Yu, Qing Li, Yang Luo, Changjun Zhu… in BMC Cancer (2016)

Article

53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells

Mutations in DNA damage response factors BRCA1 and BRCA2 confer sensitivity to poly(ADP-ribose) polymerase (PARP) inhibitors in breast and ovarian cancers. BRCA1/BRCA2-defective tumors can exhibit resistance t...

Ruoxi Hong, Fei Ma, Weimin Zhang, **ying Yu, Qing Li, Yang Luo, Changjun Zhu… in BMC Cancer (2016)